Volume Watch Alert On: (OTCQB: ACTC), (OTCQB: USGT)
Advanced Cell Technology, Inc. (OTCQB: ACTC) a leader in the field of regenerative medicine, recently announced that it has reached a settlement agreement with CAMOFI and CAMZHN Master LDC resolving a lawsuit filed against ACT in the Supreme Court of New York relating to the conversion price of certain notes and the exercise price of certain warrants.
View full press release